Literature DB >> 7507318

Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages.

A Hrabák1, T Bajor, A Temesi.   

Abstract

Arginine utilizing enzymes in macrophages showed different specificities for various arginine analogues and derivatives as substrates and inhibitors. Isolated arginase was strongly inhibited by L-canavanine(Can) and L-ornithine(Orn) but only slightly by L-homoarginine(Hom) and L-argininamide(ArgNH2). These effects were not or only weakly observed when released urea was measured in long term cell cultures. On the other hand, both L-canavanine and L-argininamide were substrates for arginase in long-term cultures. The known inhibitors of NO synthase were ineffective. The mechanisms of inhibition were different for L-canavanine and L-ornithine, but clear mechanisms could not be identified). NO synthase was studied only in long term cell cultures without purification. Certain N-guanidino (NG)-substituted arginine derivatives caused a marked inhibition while inhibitors of arginase had only slight or no effect. L-homoarginine was also found to be the substrate of NO synthase. The comparison of these effects of arginine analogues and derivatives made possible a computer-aided approximation for the fitting of active centers of these enzymes to their substrates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507318     DOI: 10.1006/bbrc.1994.1029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Common ligands of G-protein-coupled receptors and arginine-utilizing enzymes.

Authors:  András Hrabák
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 2.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

3.  Characterization of nitric oxide synthase activity in sheep urinary tract: functional implications.

Authors:  A García-Pascual; G Costa; A Labadia; K Persson; D Triguero
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.

Authors:  Christiane Drechsler; Andreas Meinitzer; Stefan Pilz; Vera Krane; Andreas Tomaschitz; Eberhard Ritz; Winfried März; Christoph Wanner
Journal:  Eur J Heart Fail       Date:  2011-08       Impact factor: 15.534

5.  Canavanine-induced longevity in mice may require diets with greater than 15.7% protein.

Authors:  Dan L Brown
Journal:  Nutr Metab (Lond)       Date:  2005-02-25       Impact factor: 4.169

6.  A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2.

Authors:  Roman N Rodionov; Elisa Oppici; Jens Martens-Lobenhoffer; Natalia Jarzebska; Silke Brilloff; Dmitrii Burdin; Anton Demyanov; Anne Kolouschek; James Leiper; Renke Maas; Barbara Cellini; Norbert Weiss; Stefanie M Bode-Böger
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

7.  The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B.

Authors:  Anja Chafai; Martin F Fromm; Jörg König; Renke Maas
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

8.  Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.

Authors:  Christiane Drechsler; Barbara Kollerits; Andreas Meinitzer; Winfried März; Eberhard Ritz; Paul König; Ulrich Neyer; Stefan Pilz; Christoph Wanner; Florian Kronenberg
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

9.  Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents.

Authors:  Aleksandra Jaźwińska-Kozuba; Jens Martens-Lobenhoffer; Olga Kruszelnicka; Jarosław Rycaj; Bernadeta Chyrchel; Andrzej Surdacki; Stefanie M Bode-Böger
Journal:  Int J Mol Sci       Date:  2013-11-04       Impact factor: 5.923

10.  Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?

Authors:  Tanja Raedle-Hurst; Marieke Mueller; Andreas Meinitzer; Winfried Maerz; Thomas Dschietzig
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.